GxE interaction effects of HCRTR2 single nucleotide polymorphism and adverse childhood experiences on methamphetamine use disorder

References

• UNODC. Drug market trends of cocain, amphetamine-type stimulants and new pyschoactive substances. Vienna, Austria: United Nations publication; 2022.
   Google Scholar
• Paulus MP, Neurobiology SJ. Clinical presentation, and treatment of methamphetamine use disorder: a review. JAMA Psychiarty. 2020;77:959–66. doi:10.1001/jamapsychiatry.2020.0246.
   PubMed Web of Science ®Google Scholar
• Lee W-C, Chang H-M, Huang M-C, Pan C-H, Su S-S, Tsai S-Y, Chen C-C, Kuo C-J. All-cause and suicide mortality among people with methamphetamine use disorder: a nation-wide cohort study in Taiwan. Addiction. 2021;116:3127–38. doi:10.1111/add.15501.
   PubMed Web of Science ®Google Scholar
• Chen Y-H, Chen M-H, Wei H-T, Chen L-Y. Survey of substance use among adolescent drug offenders referred from juvenile courts in Taiwan: clinical epidemiology of single versus multiple illicit substance use. J Formos Med Assoc. 2022;121:2257–64. doi:10.1016/j.jfma.2022.04.009.
   PubMed Web of Science ®Google Scholar
• Lin C-C, Weng T-I, Ng C-J, Shih C-P, Hsu J, Liao Y-C, Yang C-C, Fang C-C. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan emergency department drug abuse surveillance (TEDAS) project. Clinical Toxicology. 2022;60:708–15. doi:10.1080/15563650.2022.2038793.
   PubMed Web of Science ®Google Scholar
• de Lecea L, Kilduff TS, Peyron C, Gao X-B, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett F, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci. 1998;95:322–27. doi:10.1073/pnas.95.1.322.
   PubMed Web of Science ®Google Scholar
• Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573–85. doi:10.1016/S0092-8674(00)80949-6.
   PubMed Web of Science ®Google Scholar
• Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18:9996–10015. doi:10.1523/jneurosci.18-23-09996.1998.
   PubMed Web of Science ®Google Scholar
• Sutcliffe JG, de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res. 2000;62:161–68. doi:10.1002/1097-4547(20001015)62:2<161:AID-JNR1>3.0.CO;2-1.
   PubMed Web of Science ®Google Scholar
• Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005;437:556–9. doi:10.1038/nature04071.
   PubMed Web of Science ®Google Scholar
• Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P, Richardson KA. Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction. Brain Res. 2010;1314:74–90. doi:10.1016/j.brainres.2009.09.106.
   PubMed Web of Science ®Google Scholar
• Koob GF. A role for brain stress systems in addiction. Neuron. 2008;59:11–34. doi:10.1016/j.neuron.2008.06.012. PubMed PMID: 18614026; PubMed Central PMCID: PMC2748830.
   PubMed Web of Science ®Google Scholar
• Sharf R, Sarhan M, Dileone RJ. Role of orexin/hypocretin in dependence and addiction. Brain Res. 2010;1314:130–8. doi:10.1016/j.brainres.2009.08.028. PubMed PMID: 19699189; PubMed Central PMCID: PMC2819591.
   PubMed Web of Science ®Google Scholar
• Giardino WJ, de Lecea L. Hypocretin (orexin) neuromodulation of stress and reward pathways. Curr Opin Neurobiol. 2014;29:103–8. doi:10.1016/j.conb.2014.07.006.
   PubMed Web of Science ®Google Scholar
• Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, Schmeichel B, Vendruscolo LF, Wade CL, Whitfield Jr TW, et al. Addiction as a stress surfeit disorder. Neuropharmacology. 2014;76:370–82. doi:10.1016/j.neuropharm.2013.05.024. PubMed PMID: 23747571; PubMed Central PMCID: PMC3830720.
   PubMed Web of Science ®Google Scholar
• Herrera DG, Robertson HA. Activation of c-fos in the brain. Prog Neurobiol. 1996;50:83–107. doi:10.1016/S0301-0082(96)00021-4.
   PubMed Web of Science ®Google Scholar
• Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, Scammell TE. Fos expression in orexin neurons varies with behavioral state. J Neurosci. 2001;21:1656–62. doi:10.1523/jneurosci.21-05-01656.2001. PubMed PMID: 11222656; PubMed Central PMCID: PMC6762959.
   PubMed Web of Science ®Google Scholar
• Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol. 2006;148:752–9. doi:10.1038/sj.bjp.0706789. PubMed PMID: 16751790; PubMed Central PMCID: PMC1617074.
   PubMed Web of Science ®Google Scholar
• Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci. 2008;105:19480–85. doi:10.1073/pnas.0808023105.
   PubMed Web of Science ®Google Scholar
• Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci. 2005;102:19168–73. doi:10.1073/pnas.0507480102.
   PubMed Web of Science ®Google Scholar
• Zlebnik NE, Holtz NA, Lepak VC, Saykao AT, Zhang Y, Carroll ME. Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior. Drug Alcohol Depen. 2021;224:108719. doi:10.1016/j.drugalcdep.2021.108719.
   PubMed Web of Science ®Google Scholar
• Khosrowabadi E, Karimi-Haghighi S, Jamali S, Haghparast A. Differential roles of intra-accumbal orexin receptors in acquisition and expression of methamphetamine-induced conditioned place preference in the rats. Neurochem Res. 2020;45:2230–41. doi:10.1007/s11064-020-03084-1.
   PubMed Web of Science ®Google Scholar
• Majidinezhad M, Amirteymouri H, Karimi-Haghighi S, Kourosh-Arami M, Haghparast A. Orexin system in the ventral tegmental area is implicated in the rewarding properties of methamphetamine. Eur J Pharmacol. 2022;930:175170. doi:10.1016/j.ejphar.2022.175170.
   PubMed Web of Science ®Google Scholar
• Amirteymori H, Karimi-Haghighi S, Mirmohammadi M, Majidinezhad M, Khosrowabadi E, Haghparast A. Hypocretin/Orexin system in the nucleus accumbens as a promising player in the extinction and reinstatement of methamphetamine-induced CPP. Prog Neuropsychopharmacol Biol Psychiatry. 2023;120:110616. doi:10.1016/j.pnpbp.2022.110616.
   PubMed Web of Science ®Google Scholar
• Amirteymori H, Veisi A, Khaleghzadeh-Ahangar H, Mozafari R, Haghparast A. Involvement of orexin-2 receptors in the CA1 region of the hippocampus in the extinction and reinstatement of methamphetamine-induced conditioned place preference in the rats. Peptides. 2023;160:170926. doi:10.1016/j.peptides.2022.170926.
   PubMed Web of Science ®Google Scholar
• Nazari-Serenjeh F, Azizbeigi R, Rashvand M, Mesgar S, Amirteymori H, Haghparast A. Distinct roles for orexin-1 and orexin-2 receptors in the dentate gyrus of the hippocampus in the methamphetamine-seeking behavior in the rats. Life Sci. 2023;312:121262. doi:10.1016/j.lfs.2022.121262.
   PubMed Web of Science ®Google Scholar
• Chen W-Y, Kao C-F, Chen P-Y, Lin S-K, Huang M-C. Orexin-a level elevation in recently abstinent male methamphetamine abusers. Psychiatry Res. 2016;239:9–11. doi:10.1016/j.psychres.2016.02.059.
   PubMed Web of Science ®Google Scholar
• Pulver A, Kiive E, Kanarik M, Harro J. Association of orexin/hypocretin receptor gene (HCRTR1) with reward sensitivity, and interaction with gender. Brain Res. 2020;1746:147013. doi:10.1016/j.brainres.2020.147013.
   PubMed Web of Science ®Google Scholar
• Nishizawa D, Kasai S, Hasegawa J, Sato N, Yamada H, Tanioka F, Nagashima M, Katoh R, Satoh Y, Tagami M, et al. Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies. Mol Brain. 2015;8:50.
   PubMed Web of Science ®Google Scholar
• Enoch M-A. The influence of gene–environment interactions on the development of alcoholism and drug dependence. Curr Psychiatry Rep. 2012;14:150–8. doi:10.1007/s11920-011-0252-9.
   PubMed Web of Science ®Google Scholar
• Dube SR, Felitti VJ, Dong M, Chapman DP, Giles WH, Anda RF. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. 2003;111:564–72. doi:10.1542/peds.111.3.564.
   PubMed Web of Science ®Google Scholar
• Ding Y, Lin H, Zhou L, Yan H, He N. Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis. Drug Alcohol Depen. 2014;142:295–300. doi:10.1016/j.drugalcdep.2014.06.042.
   PubMed Web of Science ®Google Scholar
• Forster M, Grigsby TJ, Rogers CJ, Benjamin SM. The relationship between family-based adverse childhood experiences and substance use behaviors among a diverse sample of college students. Addict Behav. 2018;76:298–304. doi:10.1016/j.addbeh.2017.08.037.
   PubMed Web of Science ®Google Scholar
• Leza L, Siria S, López-Goñi JJ, Fernández-Montalvo J. Adverse childhood experiences (ACEs) and substance use disorder (SUD): a scoping review. Drug Alcohol Depen. 2021;221:108563. doi:10.1016/j.drugalcdep.2021.108563.
   PubMed Web of Science ®Google Scholar
• Lee W-C, Fang S-C, Chen Y-Y, Liu H-C, Huang M-C, McKetin R. Exploring the mediating role of methamphetamine use in the relationship between adverse childhood experiences and attempted suicide. Addict Behav. 2021;123:107060. doi:10.1016/j.addbeh.2021.107060.
   PubMed Web of Science ®Google Scholar
• Pasman JA, Verweij KJH, Abdellaoui A, Hottenga JJ, Fedko IO, Willemsen G, Boomsma DI, Vink JM. Substance use: interplay between polygenic risk and neighborhood environment. Drug Alcohol Depen. 2020;209:107948.
   PubMed Web of Science ®Google Scholar
• Mishra AA, Marceau K, Christ SL, Schwab Reese LM, Taylor ZE, Knopik VS. Multi-type childhood maltreatment exposure and substance use development from adolescence to early adulthood: a GxE study. Child Abuse Neglect. 2022;126:105508. doi:10.1016/j.chiabu.2022.105508.
   PubMed Web of Science ®Google Scholar
• Hikida T, Morita M, Kuroiwa M, Macpherson T, Shuto T, Sotogaku N, Niwa M, Sawa A, Nishi A. Adolescent psychosocial stress enhances sensitization to cocaine exposure in genetically vulnerable mice. Neurosci Res. 2020;151:38–45.
   PubMed Web of Science ®Google Scholar
• Chen WJ, Liu SK, Chang C-J, Lien Y-J, Chang Y-H, Hwu H-G. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry. 1998;155:1214–20. doi:10.1176/ajp.155.9.1214. PubMed PMID: 9734545.
   PubMed Web of Science ®Google Scholar
• Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the adverse childhood experiences (ACE) study. American Journal Of Preventive Medicine. 1998;14:245–58. doi:10.1016/S0749-3797(98)00017-8.
   PubMed Web of Science ®Google Scholar
• Rainero I, Rubino E, Valfrè W, Gallone S, De Martino P, Zampella E, Pinessi L. Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis. J Headache Pain. 2007;8:152–6. doi:10.1007/s10194-007-0383-x.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57:289–300. doi:10.1111/j.2517-6161.1995.tb02031.x.
   Web of Science ®Google Scholar
• Schürks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology. 2006;66:1917–19. doi:10.1212/01.wnl.0000215852.35329.34. PubMed PMID: 16554494.
   PubMed Web of Science ®Google Scholar
• Annerbrink K, Westberg L, Olsson M, Andersch S, Sjödin I, Holm G, Allgulander C, Eriksson E. Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene. Psychiatric Genetics. 2011;21:85–89. doi: 10.1097/YPG.0b013e328341a3db. PubMed PMID: 00041444-201104000-00004.
   PubMed Web of Science ®Google Scholar
• Firouzabadi N, Navabzadeh N, Moghimi-Sarani E, Haghnegahdar M. Orexin/Hypocretin type 2 receptor (HCRTR2) gene as a candidate gene in sertraline-associated insomnia in depressed patients. Neuropsychiatr Dis Treat. 2020;16:1121–8. doi:10.2147/ndt.S250141. PubMed PMID: 32440126; PubMed Central PMCID: PMC7210038.
   PubMed Web of Science ®Google Scholar
• Rainero I, Gallone S, Rubino E, Ponzo P, Valfre W, Binello E, Fenoglio P, Gentile S, Anoaica M, Gasparini M, et al. Haplotype analysis confirms the association between the HCRTR2 gene and cluster headache. Headache. 2008;48:1108–14. doi:10.1111/j.1526-4610.2008.01080.x.
   PubMed Web of Science ®Google Scholar
• Briggs EC, Amaya-Jackson L, Putnam KT, Putnam FW. All adverse childhood experiences are not equal: the contribution of synergy to adverse childhood experience scores. Am Psychol. 2021;76:243–52. doi:10.1037/amp0000768. PubMed PMID: 33734792.
   PubMed Web of Science ®Google Scholar
• Huang M-C, Schwandt ML, Ramchandani VA, George DT, Heilig M. Impact of multiple types of childhood trauma exposure on risk of psychiatric comorbidity among alcoholic inpatients. Alcohol. 2012;36:1099–107. doi:10.1111/j.1530-0277.2011.01695.x.
   Web of Science ®Google Scholar
• Hughes K, Bellis MA, Hardcastle KA, Sethi D, Butchart A, Mikton C, Jones L, Dunne MP. The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. The Lancet Public Health. 2017;2:e356–66. doi:10.1016/S2468-2667(17)30118-4.
   PubMed Web of Science ®Google Scholar
• Tang S, Jones CM, Wisdom A, Lin H-C, Bacon S, Houry D. Adverse childhood experiences and stimulant use disorders among adults in the United States. Psychiatry Res. 2021;299:113870. doi:10.1016/j.psychres.2021.113870.
   PubMed Web of Science ®Google Scholar
• Wang B, You Z-B, Wise RA. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol Psychiatry. 2009;65:857–62. doi:10.1016/j.biopsych.2009.01.018.
   PubMed Web of Science ®Google Scholar
• Tung L-W, Lu G-L, Lee Y-H, Yu L, Lee H-J, Leishman E, Bradshaw H, Hwang L-L, Hung M-S, Mackie K, et al. Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons. Nat Commun. 2016;7:12199.
   PubMed Web of Science ®Google Scholar
• Nishino S. Chapter 47 - hypothalamus, hypocretins/orexin, and vigilance control. In: Montagna P, and S Chokroverty, editors. Handbook of clinical neurology. Vol. 99. Amsterdam, Netherlands: Elsevier; 2011. p. 765–82.
   Google Scholar
• Schmeichel BE, Herman MA, Roberto M, Koob GF. Hypocretin neurotransmission within the central amygdala mediates escalated cocaine self-administration and stress-induced reinstatement in rats. Biol Psychiatry. 2017;81:606–15. doi:10.1016/j.biopsych.2016.06.010.
   PubMed Web of Science ®Google Scholar